Article: | MedLuna.com

Overview

Journal Med Trop Sante Int

Specialty Public Health

Date 2024 Nov 22

PMID 39575094

Authors

Houehanou Rodrigue Gnangnon Freddy

Aboudou Raimi Kpossou

Koffi Ntcha

Salmane Ariyah Amidou

Vincent Zossou

Cosme Toume

Rodrigue S Allodji

Dismand Stephan Houinato

Dansou Gaspard Gbessi

Jean Sehonou

Affiliations

Soon will be listed here.

Citing Articles

[Hepatocellular carcinoma (HCC)].

Pol S Med Trop Sante Int. 2025; 4(4).

PMID: 40070978 PMC: 11892391. DOI: 10.48327/mtsi.v4i4.2024.614.

References

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View

Joshi S, Song Y, Kim T, Cho S . Socio-economic status and the risk of liver cancer mortality: a prospective study in Korean men. Public Health. 2008; 122(11):1144-51. DOI: 10.1016/j.puhe.2008.04.003. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Mirzaei M, Ghoncheh M, Pournamdar Z, Soheilipour F, Salehiniya H . Incidence and Trend of Liver Cancer in Iran. J Coll Physicians Surg Pak. 2016; 26(4):306-9. DOI: 2297. View

Maluccio M, Covey A . Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012; 62(6):394-9. DOI: 10.3322/caac.21161. View

Zamor P, deLemos A, Russo M . Viral hepatitis and hepatocellular carcinoma: etiology and management. J Gastrointest Oncol. 2017; 8(2):229-242. PMC: 5401856. DOI: 10.21037/jgo.2017.03.14. View

Lemoine M, Thursz M . Battlefield against hepatitis B infection and HCC in Africa. J Hepatol. 2016; 66(3):645-654. DOI: 10.1016/j.jhep.2016.10.013. View

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

Llovet J, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M . Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2:16018. DOI: 10.1038/nrdp.2016.18. View

10.

Kihn-Alarcon A, Toledo-Ponce M, Velarde A, Xu X . Liver Cancer in Guatemala: An Analysis of Mortality and Incidence Trends From 2012 to 2016. J Glob Oncol. 2019; 5:1-8. PMC: 6426540. DOI: 10.1200/JGO.18.00179. View

11.

Khalaf N, Ying J, Mittal S, Temple S, Kanwal F, Davila J . Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2016; 15(2):273-281.e1. DOI: 10.1016/j.cgh.2016.07.033. View

12.

McGlynn K, London W . The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis. 2011; 15(2):223-43, vii-x. PMC: 4141529. DOI: 10.1016/j.cld.2011.03.006. View

13.

Yabroff K, Lund J, Kepka D, Mariotto A . Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011; 20(10):2006-14. PMC: 3191884. DOI: 10.1158/1055-9965.EPI-11-0650. View

14.

Lin Y, Lin C, Sedghi T, Hsu S, Gross C, Wang J . Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan. PLoS One. 2020; 15(10):e0240542. PMC: 7556438. DOI: 10.1371/journal.pone.0240542. View

15.

Chen W, Zheng R, Zhang S . Liver cancer incidence and mortality in China, 2009. Chin J Cancer. 2013; 32(4):162-9. PMC: 3845572. DOI: 10.5732/cjc.013.10027. View

16.

Ding C, Fu X, Zhou Y, Liu X, Wu J, Huang C . Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases. BMJ Open. 2019; 9(4):e025613. PMC: 6500226. DOI: 10.1136/bmjopen-2018-025613. View

17.

Ryerson A, Eheman C, Altekruse S, Ward J, Jemal A, Sherman R . Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016; 122(9):1312-37. PMC: 4840031. DOI: 10.1002/cncr.29936. View

18.

Brar G, Greten T, Graubard B, McNeel T, Petrick J, McGlynn K . Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis. Hepatol Commun. 2020; 4(10):1541-1551. PMC: 7527688. DOI: 10.1002/hep4.1564. View

19.

Parkin D . International variation. Oncogene. 2004; 23(38):6329-40. DOI: 10.1038/sj.onc.1207726. View

20.

Kew M . Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology. 1981; 1(4):366-9. DOI: 10.1002/hep.1840010415. View